Lihua Shen - Sino Medical Financial Director
| 688108 Stock | 10.71 0.41 3.98% |
Director
Lihua Shen is Financial Director of Sino Medical Sciences
| Age | 54 |
| Address | TEDA Biomedical R&D Building, Tianjin, China, 300457 |
| Phone | 86 22 5986 2900 |
| Web | https://www.sinomed.com |
Sino Medical Management Efficiency
The company has return on total asset (ROA) of (0.0247) % which means that it has lost $0.0247 on every $100 spent on assets. This is way below average. Sino Medical's management efficiency ratios could be used to measure how well Sino Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Sino Medical's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 16.9 M, whereas Total Assets are forecasted to decline to about 1 B.Similar Executives
| Found 14 records | DIRECTOR Age | ||
| Shiping Yan | Sportsoul Co Ltd | 48 | |
| Xianghong Yan | Uroica Mining Safety | N/A | |
| Tong Che | Wasu Media Holding | 54 | |
| Baohang Cui | Uroica Mining Safety | 46 | |
| Jianping Dong | Guocheng Mining Co | 57 | |
| Ziping Deng | Guocheng Mining Co | 52 | |
| He Lei | Southern PublishingMedia Co | 54 | |
| Zhiqiang Wu | Sportsoul Co Ltd | 42 | |
| He Ye | Southern PublishingMedia Co | 53 | |
| Yong Li | Guangdong Jinma Entertainment | 59 | |
| Yanbing Xiao | Southern PublishingMedia Co | 52 | |
| Wu Jie | Wasu Media Holding | 49 | |
| Mingtao Jiang | Southern PublishingMedia Co | 59 | |
| Ziqiang Shen | Wasu Media Holding | 52 | |
Management Performance
| Return On Equity | 0.0017 | ||||
| Return On Asset | -0.0247 |
Sino Medical Sciences Leadership Team
Elected by the shareholders, the Sino Medical's board of directors comprises two types of representatives: Sino Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sino. The board's role is to monitor Sino Medical's management team and ensure that shareholders' interests are well served. Sino Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sino Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Liye Cui, Deputy Operation | ||
| Xiaoran Kang, Deputy Director | ||
| Jianhua Sun, Gen Chairman | ||
| Lihua Shen, Financial Director | ||
| Kai Huang, Board Director | ||
| Meihong Li, Accounting Supervisor | ||
| Xiangfei Miao, Senior Director |
Sino Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sino Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0017 | ||||
| Return On Asset | -0.0247 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 4.17 B | ||||
| Shares Outstanding | 413.46 M | ||||
| Shares Owned By Insiders | 33.74 % | ||||
| Shares Owned By Institutions | 9.61 % | ||||
| Price To Book | 4.97 X | ||||
| Price To Sales | 9.76 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sino Stock
Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.